Advisory · June 2026

Dandruff

What it is, what it isn’t, and the small set of things that actually work.

Reading time · 6 minutes
Dandruff

Dandruff is the most over-treated and most misunderstood scalp condition. It is also one of the easiest to manage once you stop treating it as a hygiene problem and start treating it as what it actually is: an inflammatory response of the scalp to commensal yeast, in people whose skin is set up to react that way.1

About half the adult population gets dandruff at some point.2 It is not contagious, not caused by poor washing, and not a sign of an unclean scalp. Some of the cleanest scalps shed the most. The condition is constitutional — partly genetic, partly hormonal, partly environmental — and the visible flake is the end of a chain that begins much earlier.

What is actually happening

The scalp hosts Malassezia yeast as part of its normal microbiome.3 In susceptible people, Malassezia metabolises sebum into free fatty acids — particularly oleic acid — which irritate the skin and disrupt the stratum corneum.1 The skin responds with accelerated cell turnover. Instead of shedding invisibly over four weeks, cells shed in visible clumps over one to two weeks.4

This is why three things are simultaneously true: dandruff is not a fungal infection, it does respond to antifungal treatment, and it tends to return. The yeast is a normal resident. The reaction to it is the problem.

Dandruff, seborrhoeic dermatitis, psoriasis

These three sit on a spectrum and are often confused. Dandruff is the mildest end: dry-looking white or grey flakes, mild itch, no redness, no spread beyond the scalp.5

Seborrhoeic dermatitis is the same biological process turned up. Flakes become greasier and yellower. The skin underneath is visibly red and inflamed. It often spreads to the eyebrows, the sides of the nose, the ears, and the central chest.6 The treatments overlap, but seborrhoeic dermatitis usually needs anti-inflammatory help alongside the antifungal.

Scalp psoriasis is a different condition that can mimic both. The scale is thicker, silvery, and sits on well-defined plaques that often extend past the hairline.7 Psoriasis does not resolve with anti-dandruff shampoo alone.

The practical signal: if the scalp looks angry and the skin is involved beyond shedding, it is no longer simple dandruff.

What actually works

The evidence on dandruff treatment is unusually clear for a cosmetic condition. Five active ingredients have repeatedly shown effect in randomised trials:8

The point worth keeping is this: the active ingredient matters, the brand does not. Two products with the same active at the same concentration perform equivalently in trials.

How to use them: lather, leave on the scalp for two to five minutes, then rinse. Most treatment failures come from rinsing too immediately. The active needs contact time to work. Two to three uses per week for several weeks resolves most cases. After clearance, a single weekly use as maintenance prevents relapse.12

What does not work

Daily aggressive washing with regular shampoo makes dandruff worse, not better. It strips the barrier, increases turnover, and recruits more inflammation. Twice-weekly washing with an active shampoo and gentle cleansing on other days suits most scalps.

“Anti-dandruff” products without one of the active ingredients above — those relying on tea tree oil alone, “purifying” botanicals, or vague “scalp-balancing” claims — perform no better than placebo in head-to-head trials.

Stress, sleep loss, and cold dry climates worsen dandruff. They are not the cause, but they reliably trigger flares in people who already have the underlying tendency.

When to see a clinician

See a clinician if: flakes persist for more than six to eight weeks of consistent treatment with an evidence-based active; the scalp is visibly red, painful, or weeping; the condition spreads to the face, chest, or other areas; there is hair loss in the affected zones; or what looks like dandruff is actually patches of scaling with broken hairs underneath, which can indicate tinea capitis or scarring conditions.

Most dandruff settles with the right active used correctly. The minority that does not is worth investigating, because the wrong diagnosis treated for months produces frustration on the patient side and missed pathology on the clinical side.

Dandruff is not a moral failing. It is not an infection. It is a chronic, manageable, common feature of the scalp microbiome in interaction with the skin it lives on. Treat it as such, and most of the noise around it falls away.

Sources

  1. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2).
  2. Misery L, Touboul S, Vinçot C, et al. [Stress and seborrheic dermatitis]. Ann Dermatol Venereol. 2007;134(11):833–7.
  3. Saunte DML, Gaitanis G, Hay RJ. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Front Cell Infect Microbiol. 2020;10:112.
  4. Ranganathan S, Mukhopadhyay T. Dandruff: the most commercially exploited skin disease. Indian J Dermatol. 2010;55(2):130–4.
  5. Schwartz JR, Messenger AG, Tosti A, et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. Acta Derm Venereol. 2013;93(2):131–7.
  6. Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009;360(4):387–96.
  7. Blakely K, Gooderham M. Management of scalp psoriasis: current perspectives. Psoriasis (Auckl). 2016;6:33–40.
  8. Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15(6):434–41.
  9. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008–12.
  10. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995;132(3):441–5.
  11. Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004;43 Suppl 1:17–20.
  12. Schwartz JR. Zinc pyrithione: a topical antimicrobial with complex pharmaceutics. J Drugs Dermatol. 2016;15(2):140–4.
← Back to Advisory